News

Everon Biosciences Introduces Physiological Frailty Index as a Measure of Biological Age in Mice, Enhancing the Development of Healthspan-Extending Pharmaceuticals

BUFFALO, N.Y., March 21, 2017 /PRNewswire/ -- Today, a research team from Everon Biosciences, Inc. and the Roswell Park Cancer Institute has published a new study describing a methodology for determining a physiological frailty index (PFI) as a measure of biological age in laboratory mice. The paper provides a new robust, non-invasive, quantitative technique suitable [...]

Andrei Gudkov taped an expanded presentation of the slides he presented at 2017 Biology of Aging conference at Scripps, Florida, 22-27 January

At the conference Andrei Gudkov, Everon Biosciences CSO, presented a talk covering a broad range of aging-related discoveries and inventions made by Everon scientists in partnership with Roswell Park Cancer Institute. That talk had to fit in about 20 min – too short to do justice to the material he presented. Several people came to [...]

Everon Biosciences Publishes a Study Suggesting a New Biomarker of Senescent Cells for Anti-Aging Research and Drug Development

BUFFALO, N.Y., Feb. 15, 2017 /PRNewswire/ -- Today, a research team from Everon Biosciences, Inc. and Roswell Park Cancer Institute has published a new study in Proceedings of the National Academy of Sciences of the United States of America (PNAS) describing a new biomarker of senescent cells and a specific monoclonal antibody that could potentially be used to develop [...]

Everon Biosciences is planning a big showing at The Biology of Aging conference in Jupiter, Florida on January 22-25, 2017.

Everon Biosciences is planning a big showing at The Biology of Aging conference in Jupiter, Florida on January 22-25, 2017. In addition to the invited talk by Dr. Andrei Gudkov, our CSO, company’s scientific and technological achievements will be presented in 5 posters. Among notable results is the disclosure of Everon’s first drug candidate that [...]

Roswell Park Cancer Institute Interviews Dr. Andrei Gudkov About New Target for Age-related Disease

Video courtesy of Roswell Park Cancer Institute

Everon Co-Founder Says Weak Stresses May Be Key to Extending Lifespan

In a paper published in the journal Aging, Dr. Mikhail V. Blagosklonny, hypothesizes that stresses, such as weak oxidative stress, heat shock, hypoxia, and calorie restriction, could actually stimulate maintenance and repair pathways.  Activation of these pathways could lead to adaptation of the cells and their ability tolerate the stronger stresses that occur later in [...]

Dr. Andrei Gudkov Describes New Drug Target for Anti-Aging Therapies

At the 2016 International Cell Senescence Association Conference, Dr. Andrei Gudkov, CSO of Everon, explains why senescent cells may not be the only drug target for anti-aging therapies In the presentation, Dr. Gudkov discusses findings from a study published earlier this month in the journal Aging, which identified a subset of immune cells, which the [...]

Everon Biosciences Introduces New Age-Related Cellular Target That Changes Focus of Antiaging Drug Discovery

BUFFALO, New York, July 6, 2016 -- A research team from Everon Biosciences, Inc. and Roswell Park Cancer Institute has identified a specific subpopulation of immune cells accumulating in old mice that are likely contributors to aging and age-related diseases. Previously, this function had been solely attributed to senescent cells, which have been declared to [...]